Search

Your search keyword '"Wils, J."' showing total 873 results
Start Over Author "Wils, J."

Refine your results

more »

more »

more »

more »
873 results on '"Wils, J."'

18. Nihilism and fiction

Author

Chouraqui, F., Bremmers, C., Smith, A., and Wils, J.

Published
2018

20. Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Author

Köhne, C H., van Cutsem, E, Wils, J, Bokemeyer, C, El-Serafi, M, Lutz, M P., Lorenz, M, Reichardt, P, Rückle-Lanz, H, Frickhofen, N, Fuchs, R, Mergenthaler, H G., Langenbuch, T, Vanhoefer, U, Rougier, P, Voigtmann, R, Müller, L, Genicot, B, Anak, Ö, and Nordlinger, B

Published
2005
Full Text
View/download PDF

23. Randomized Phase III Study of High-Dose Fluorouracil Given As a Weekly 24-Hour Infusion With or Without Leucovorin Versus Bolus Fluorouracil Plus Leucovorin in Advanced Colorectal Cancer: European Organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952

Author

Köhne, C-H., Wils, J., Lorenz, M., Schöffski, P., Voigtmann, R., Bokemeyer, C., Lutz, M., Kleeberg, U., Ridwelski, K., Souchon, R., El-Serafi, M., Weiss, U., Burkhard, O., Rückle, H., Lichinitser, M., Langenbuch, T., Scheithauer, W., Baron, B., Couvreur, M.L., and Schmoll, H.J.

Published
2003

26. Weekly high dose infusional 5-FU plus folinic acid (FA) with or without irinotecan (IRI) in metastatic colorectal cancer (MCRC): interim safety and efficacy results of EORTC study 40986: 430

Author

Köhne, C.-H., van Cutsem, E., Wils, J., Bokemeyer, C., El-Serafi, M., Lutz, M., Lorenz, M., Reichardt, P., Rückle-Lanz, H., Frickhofen, N., Fuchs, R., Mergenthaler, H.-G., Langenbuch, T., Vandebroeck, A., Douillard, J.-Y., Vanhoefer, U., Voigtmann, R., Mitry, E., Müller, L., Anak, O., Vanacker, Garzon N., Baron, B., and Nordlinger, B.

Published
2002

38. Adjuvante Chemotherapie des Magenkarzinoms

Author

Wils, J. A., Hotz, J., editor, Meyer, H.-J., editor, Schmoll, H.-J., editor, Bruckner, H. W., editor, Classen, M., editor, Feifel, G., editor, Goebell, H., editor, Grote, R., editor, Herfarth, Ch., editor, Hermanek, P., editor, Hölscher, A., editor, Jähne, J., editor, Klein, H. O., editor, Langhans, P., editor, Milbradt, H., editor, Ottenjann, R., editor, Pichlmayr, R., editor, Preusser, P., editor, Rösch, W., editor, Schlag, P., editor, Siewert, J. R., editor, Wilke, H., editor, and Wils, J. A., editor

Published
1989
Full Text
View/download PDF

39. Fortgeschrittenes Magenkarzinom: Ergebnisse von Chemotherapiestudien der EORTC-GI-Gruppe

Author

Wils, J. A., Hotz, J., editor, Meyer, H.-J., editor, Schmoll, H.-J., editor, Bruckner, H. W., editor, Classen, M., editor, Feifel, G., editor, Goebell, H., editor, Grote, R., editor, Herfarth, Ch., editor, Hermanek, P., editor, Hölscher, A., editor, Jähne, J., editor, Klein, H. O., editor, Langhans, P., editor, Milbradt, H., editor, Ottenjann, R., editor, Pichlmayr, R., editor, Preusser, P., editor, Rösch, W., editor, Schlag, P., editor, Siewert, J. R., editor, Wilke, H., editor, and Wils, J. A., editor

Published
1989
Full Text
View/download PDF

44. Treatment of Pancreatic Carcinoma: Therapeutic Nihilism?

Author

Wils, J. A., Herfarth, Ch., editor, Senn, H. J., editor, Baum, M., editor, Diehl, V., editor, von Essen, C., editor, Grundmann, E., editor, Hitzig, W., editor, Rajewsky, M. F., editor, Schlag, Peter, editor, Hohenberger, Peter, editor, and Metzger, Urs, editor

Published
1988
Full Text
View/download PDF

50. Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

Author

Popov I, Carrato A, Sobrero A, Vincent M, Kerr D, Labianca R, Bianco AR, El Serafi M, Bedenne L, Paillot B, Mini E, Sanches E, Welch J, Colette L, Praet M, Wils J, CARLOMAGNO, Chiara, Popov, I, Carrato, A, Sobrero, A, Vincent, M, Kerr, D, Labianca, R, Bianco, Ar, El Serafi, M, Bedenne, L, Paillot, B, Mini, E, Sanches, E, Welch, J, Colette, L, Praet, M, Wils, J, and Carlomagno, Chiara

Subjects
adjuvant chemotherapy, colon
Abstract

the aim of the study was the non-inferiority of raltitrexed as compared with standard 5fluorouracil-folinic acid as adjuvant chemotherapy for radically resected colon cancer patients. 993 patinets have been randomized; the enrollement was prematurely closed when 17 raltitrexed-related deaths were recorded. The toxicity was higher in patinets treated with raltitrexed. RSF and OAS were slight inferion in patinets treated with raltitrexed. In conclusion, the study failed to demonstrate the non-inferiority of raltitrexed.

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results